Science that Speaks: Advancing Research Priorities in Women’s Obesity Care
- This event has passed.
June 1, 2025 @ 3:30 pm - 5:00 pm EDT
Part of the OSSD 2025 Annual Meeting
This event is taking place live at the OSSD 2025 Annual Meeting, on Sunday, June 1 at 1:30 p.m. MT in Albuquerque, NM.
The Society for Women’s Health Research (SWHR) is committed to advancing women’s health through science, policy, and education while promoting research on sex differences to optimize women’s health. Although research has documented sex differences in metabolism and cardiometabolic diseases, there remains insufficient investment in studying sex, gender, and hormone differences in obesity, and inclusion of women from diverse subpopulations in clinical studies. This session will discuss gaps in obesity research and care that contribute to health disparities among women and highlight opportunities to engage in advocacy for more holistic policy solutions. It will also examine how communication practices between scientific and policy communities shape our ability to increase investment, reduce stigma, and influence meaningful change in across the health care ecosystem.
This event includes:
Calling for Change: Elevating the Women’s Health Lens in Obesity Research, presented by Irene O. Aninye, PhD, Chief Science Officer, Society for Women’s Health Research
Weight and obesity impact health across the lifespan, with unique sex- and gender-based challenges for women. Comprehensive approaches to metabolic health care must incorporate sex differences analyses, as well as recognize how stigma, access, and clinical decision-making impact women and vary by population. This presentation will provide a focused overview of the role and challenges of obesity in improving health outcomes for women. The speaker will share how SWHR has worked to advance obesity research and care in women, and highlight research questions, clinical strategies, and policy solutions that SWHR proposes to address persistent gaps and disparities needing national and global attention.
Communicating for Change: Maximizing Accuracy, Impact, and Reach, presented by Syreen Goulmamine, MPH, Science Programs Manager, Society for Women’s Health Research
Science communication shapes research impact, especially in areas like obesity, where stigma, bias, and knowledge gaps persist. Current narratives around obesity tend to obscure the biological and hormonal underpinnings of metabolic health, hyperfocus on individual behavior, and underplay the roles of life stage, health care access, and other determinants of health for women. These errors will perpetuate if communication strategies are unable to effectively explain the science to key stakeholders with the capacity to make meaningful change in their spheres of influence. When scientific goals and data are not communicated in a way that is valuable to the intended audiences, critical work risks being overlooked and under-appreciated. For obesity in women, research must be framed to clearly respond to public health needs, and at the highest level of effect, scientific storytelling drives others to internalize content, assume ownership of the cause, and champion actionable change. Attendees will be encouraged to examine how their own communication practices may unintentionally reinforce these patterns and how reframing the science can drive more equitable research and policy outcomes.
Find more information about the OSSD 2025 Annual Meeting here.
Speakers
Irene O. Aninye, PhD
Irene O. Aninye, PhD
Dr. Irene O. Aninye is the Chief Science Officer for the Society for Women’s Health Research, a national nonprofit dedicated to advancing women’s health through science, policy, and education. Aninye steers SWHR’s portfolio of scientific programs to increase awareness and investment in research on biological sex differences and health conditions that disproportionately or uniquely affect women. She convenes expert working groups and meetings to identify strategies that address persistent gaps in women’s health care and research, translating recommendations into science-based and patient-centered policy solutions. Dr. Aninye has led the development of white papers, health care roadmaps, patient toolkits, clinical education materials, and calls to action for women’s cardiovascular health, autoimmune diseases, menopause, Alzheimer’s disease, HPV, and endometriosis, among other areas. Prior to SWHR, Aninye worked at the American Association for the Advancement of Science, specializing in research capacity building and evaluating STEM research and training programs for universities and funding agencies. With a PhD in Molecular and Integrative Physiology from the University of Illinois at Urbana-Champaign, Dr. Aninye’s research background is in endocrinology and metabolism – investigating sex steroid hormones and their receptor-mediated actions in development, reproduction, and disease. She has a passion to diversify the face of STEM and involvement of underrepresented groups in the sciences, providing scientific and leadership training across all career stages and serving on advisory boards for the National Institutes of Health, American Cancer Society, National Health Council, and World Economic Forum’s Global Alliance for Women’s Health.
Syreen Goulmamine, MPH
Syreen Goulmamine, MPH
Syreen Goulmamine, MPH, is a scientist and public health expert with a passion for advancing equitable outcomes in women’s health. She currently serves as Science Programs Manager at the Society for Women’s Health Research (SWHR), where she leads multidisciplinary initiatives to address critical research gaps in women’s health. Goulmamine brings a unique perspective shaped by her experience in academia, the biopharmaceutical industry, and public health practice at the local and state levels. She previously worked as a clinical trials report writer and consultant for Fortune 500 companies and biotech startups before transitioning to public service roles in maternal health, infectious and noncommunicable disease epidemiology, and environmental health. She is also a proud Public Health AmeriCorps alumna.
A recognized leader in the field, Goulmamine serves on numerous advisory boards and working groups, including the FDA-CTTI Patient Engagement Collaborative, Virginia Diabetes Council Board, AcademyHealth’s Health Equity Interest Group, and the Rare Disease Diversity Coalition. She is also involved with alumni leadership at George Mason University and Randolph-Macon College and contributes as a Global Burden of Disease (GBD) Collaborator.
Goulmamine earned her Master of Public Health in Epidemiology from George Mason University and a Bachelor of Science from Randolph-Macon College. She is a member of the Beta Beta Beta Biological Honor Society and the Delta Omega Honorary Society in Public Health.